JACK PRIESTMAN

Co-founder, Salient Bio 

Jack is a Co-founder of Salient Bio – a young, fast-growing biotech spin-out that operates at the intersection of synthetic biology and robotics. Born with the vision of making diagnostics accessible to all, we design, build and operate next generation molecular diagnostic platforms. Salient Bio currently operates a state-of-the-art laboratory in the heart of London to deliver ultra low cost and high-throughput diagnostics for infectious diseases. Further, leveraging the versatility of its compact and modular designs, Salient Bio is looking to rapidly move into new areas of diagnostics, in particular next generation sequencing. Jack started his career in investment banking and private equity before co-founding Salient Bio with his two co-founders, who are both academics from Imperial College London.

 LIVE ONLINE

22 June 2021

WATCH ON DEMAND